Pharos has been supporting Coalition Plus, a Paris-based advocacy organization, and ALCS, the leading HIV NGO in Morocco, to develop an investment case for HCV treatment scale-up in Morocco. In 2016, the Moroccan Ministry of Health developed a five-year HCV strategy that included ambitious treatment targets. Pharos has been supporting the costing, cost-effectiveness, and budget impact analysis of this strategy as well as evaluating the costs of inaction and alternative scale-up trajectories. ALCS hopes to use this supplemental evidence-base to advocate for accelerated scale-up
within the country.
Team members: Lindsey Hiebert, Miloud Kaddar, Stephen Resch, Robert Hecht
This slide shows the different scale-up scenarios modeled.
Here the epidemiological impact of the different scale-up scenarios is shown.
The costs of the scale-up scenarios.
The return on investment of the scenarios.
The effect of possible price reductions on the total cost of the rapid scenario.